Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis

Cost burden of second fracture in the US Health System

(2011) Xue Song et al.   BONE

The impact of teriparatide adherence and persistence on fracture outcomes

(2011) S. Yu et al.   OSTEOPOROSIS INTERNATIONAL

Adherence and persistence in patients with severe osteoporosis treated with teriparatide

(2010) V. Ziller et al.   CURRENT MEDICAL RESEARCH AND OPINION

Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance

(2010) S. A. Foster et al.   OSTEOPOROSIS INTERNATIONAL

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

Direct healthcare costs of hip, vertebral, and non-hip, non-vertebral fractures

(2009) Nianwen Shi et al.   BONE

Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women

(2009) Dana Bliuc   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Assessing adherence to teriparatide therapy, causes of nonadherence and effect of adherence on bone mineral density measurements in osteoporotic patients at high risk for fracture

(2009) Manisha Mulgund et al.   Therapeutic Advances in Musculoskeletal Disease

Teriparatide in the treatment of osteoporosis

(2008) J. Stroup et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Relationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures

(2008) Willemijn M. Meijer et al.   CURRENT MEDICAL RESEARCH AND OPINION

Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization

(2008) J. A. Sunyecz et al.   OSTEOPOROSIS INTERNATIONAL

Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates

(2008) Shonda A Foster et al.   BMC Womens Health